Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (191-200 of 283) with videos related to

Pageof 29
Sort By:
Cancer Research|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and <i>S</i>-Adenosyl-Methionine Depletion in Human Lung AdenocarcinomaMichael J Koenig, Bernice A Agana, Jacob M Kaufman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2025
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferationArturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinibVincent A Miller, Gregory J Riely, Maureen F Zakowski, et al.
BMC Cancer|January 7, 2014
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancerMichael L Maitland, Matthew R Levine, Mario E Lacouture, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 2006
Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathwayYoon-Jin Lee, Arisa Imsumran, Mi-Young Park, et al.
Cancer Research|January 7, 2006
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27Choon-Taek Lee, Yoon-Jin Lee, Sung-Youn Kwon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinibJun Zhao, Gen Lin, Minglei Zhuo, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Proteomic patterns of preinvasive bronchial lesionsS M Jamshedur Rahman, Yu Shyr, Pinar B Yildiz, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancerXiaoying Wang, Maoteng Duan, Po-Lan Su, et al.
Pageof 29

Showing results (191-200 of 283) with videos related to

Sort By:
Pageof 29
Cancer Research|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and <i>S</i>-Adenosyl-Methionine Depletion in Human Lung AdenocarcinomaMichael J Koenig, Bernice A Agana, Jacob M Kaufman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2025
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferationArturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinibVincent A Miller, Gregory J Riely, Maureen F Zakowski, et al.
BMC Cancer|January 7, 2014
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancerMichael L Maitland, Matthew R Levine, Mario E Lacouture, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 2006
Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathwayYoon-Jin Lee, Arisa Imsumran, Mi-Young Park, et al.
Cancer Research|January 7, 2006
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27Choon-Taek Lee, Yoon-Jin Lee, Sung-Youn Kwon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinibJun Zhao, Gen Lin, Minglei Zhuo, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Proteomic patterns of preinvasive bronchial lesionsS M Jamshedur Rahman, Yu Shyr, Pinar B Yildiz, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancerXiaoying Wang, Maoteng Duan, Po-Lan Su, et al.
Pageof 29